{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:16:45Z","timestamp":1787066205684,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Linkou Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.survophthal.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:25:31Z","timestamp":1782923131000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of different intraocular therapies for non-infectious uveitis: A network meta-analysis"],"prefix":"10.1016","author":[{"given":"Hsi-An","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wun-Long","family":"Jheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Da","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Yu-Chuan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Ning","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2682-939X","authenticated-orcid":false,"given":"Yi-Hsing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2026.06.015_bib1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.semarthrit.2019.06.004","article-title":"New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review","volume":"49","author":"Rosenbaum","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2026.06.015_bib2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10792-018-0984-1","article-title":"Optimising drug therapy for non-infectious uveitis","volume":"39","author":"Shahab","year":"2019","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13023-015-0318-6","article-title":"Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis","volume":"10","author":"Denniston","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.survophthal.2026.06.015_bib4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib5","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1517\/13543784.2011.617741","article-title":"Road to remission: a comprehensive review of therapy in uveitis","volume":"20","author":"Siddique","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.survophthal.2026.06.015_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2352019","article-title":"Use of corticosteroids in non-infectious uveitis - expert consensus in Taiwan","volume":"56","author":"Chang","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.survophthal.2026.06.015_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/09273948.2020.1787463","article-title":"Efficacy and safety of corticosteroid implants in non-infectious uveitis: a systematic review with network meta-analysis","volume":"30","author":"Vieira","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2026.06.015_bib8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10238-022-00954-6","article-title":"Pathogenesis and current therapies for non-infectious uveitis","volume":"23","author":"Wu","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.survophthal.2026.06.015_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib10","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2026.06.015_bib11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1517\/17425255.2013.796928","article-title":"Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters","volume":"9","author":"Jord\u00e1n","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.749312","article-title":"Comparative efficacy and safety of advanced intravitreal therapeutic agents for noninfectious uveitis: a systematic review and network meta-analysis","volume":"13","author":"Liao","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ophtha.2024.02.019","article-title":"Treatment of noninfectious uveitic macular edema with periocular and intraocular corticosteroid therapies: a report by the American Academy of Ophthalmology","volume":"131","author":"Smith","year":"2024","journal-title":"Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.5.6.14","article-title":"Suprachoroidal corticosteroid administration: a novel route for local treatment of noninfectious uveitis","volume":"5","author":"Goldstein","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib15","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1097\/IAE.0000000000002279","article-title":"Suprachoroidal injection of triamcinolone acetonide, CLS-TA, for macular edema due to noninfectious uveitis: a randomized, phase 2 study (DOGWOOD)","volume":"39","author":"Yeh","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.06.015_bib16","first-page":"113","article-title":"Novel intraocular therapy in non-infectious uveitis of the posterior segment of the eye","volume":"2","author":"Mikhail","year":"2013","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib17","first-page":"133","article-title":"The attractiveness of network meta-analysis: a comprehensive systematic and narrative review","volume":"7","author":"Greco","year":"2015","journal-title":"Heart Lung Vessel"},{"key":"10.1016\/j.survophthal.2026.06.015_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11739-016-1583-7","article-title":"Network meta-analysis: an introduction for clinicians","volume":"12","author":"Rouse","year":"2017","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.survophthal.2026.06.015_bib19","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1007\/s00266-021-02185-8","article-title":"How to avoid making your systematic review a conventional review article","volume":"45","author":"Samargandi","year":"2021","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.survophthal.2026.06.015_bib20","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.survophthal.2026.06.015_bib21","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"Bmj 355"},{"key":"10.1016\/j.survophthal.2026.06.015_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jrsm.1373","article-title":"MetaInsight: an interactive web-based tool for analyzing, interrogating, and visualizing network meta-analyses using R-shiny and netmeta","volume":"10","author":"Owen","year":"2019","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.survophthal.2026.06.015_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/09273948.2015.1025982","article-title":"Intravitreal Triamcinolone Injection for Uveitic Macular Edema: A Randomized Clinical Study","volume":"23","author":"Shin","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2026.06.015_bib25","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ajo.2008.12.033","article-title":"Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome","volume":"147","author":"Williams","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/jop.2012.0180","article-title":"A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis","volume":"29","author":"Arcinue","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2026.06.015_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100403","article-title":"The 0.2-\u03bcg\/day fluocinolone acetonide intravitreal implant in chronic noninfectious posterior uveitis: a 3-year randomized trial in India","volume":"4","author":"Biswas","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.survophthal.2026.06.015_bib28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archopht.126.9.1191","article-title":"Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results","volume":"126","author":"Callanan","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ophtha.2024.11.021","article-title":"Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment","volume":"132","author":"Gonzales","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.06.015_bib30","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2020.04.001","article-title":"Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results","volume":"127","author":"Jaffe","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.06.015_bib31","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.06.015_bib32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ophtha.2009.11.027","article-title":"Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis","volume":"117","author":"Pavesio","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.06.015_bib34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.06.015_bib35","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial","volume":"127","author":"Yeh","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.06.015_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.623725","article-title":"Uveitis: molecular pathogenesis and emerging therapies","volume":"12","author":"Egwuagu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/eye.2011.255","article-title":"Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation","volume":"26","author":"Lee","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2026.06.015_bib38","first-page":"Cd010469","article-title":"Corticosteroid implants for chronic non-infectious uveitis","volume":"8","author":"Reddy","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2026.06.015_bib39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/14740338.2015.1041916","article-title":"Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation","volume":"14","author":"Sadiq","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.survophthal.2026.06.015_bib40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4155\/tde-2019-0051","article-title":"Preliminary evaluation of YUTIQ\u2122 (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis","volume":"10","author":"Testi","year":"2019","journal-title":"Ther Deliv"},{"key":"10.1016\/j.survophthal.2026.06.015_bib41","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00417-022-05893-2","article-title":"Fluocinolone acetonide 0.19-mg implant for the treatment of noninfectious uveitis with involvement of the posterior segment: a real-world study","volume":"261","author":"Buhl","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12348-024-00402-4","article-title":"Fluocinolone acetonide 0.2 \u00b5g\/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations","volume":"14","author":"Pleyer","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.survophthal.2026.06.015_bib43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ophtha.2017.12.038","article-title":"Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience","volume":"125","author":"Pohlmann","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.06.015_bib44","first-page":"1743","article-title":"A review of ten years of experience using dexamethasone intravitreal implants (Ozurdex) for uveitis","volume":"27","author":"Zeng","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.survophthal.2026.06.015_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.06.015_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12824","article-title":"Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis","volume":"1358","author":"Whitcup","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.survophthal.2026.06.015_bib47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/OPTH.S393662","article-title":"Treatment of Non-Infectious Posterior Uveitis with Dexamethasone Intravitreal Implants in a Real-World Setting","volume":"17","author":"Butt","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib48","article-title":"Efficacy of different routes of triamcinolone acetonide administration on macular edema: A systematic review and network meta-analysis","volume":"20","author":"Liu","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2026.06.015_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/0301-4738.25840","article-title":"Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice","volume":"54","author":"Vedantham","year":"2006","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajo.2018.07.003","article-title":"Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis","volume":"194","author":"Ganapathy","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib51","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.18240\/ijo.2020.07.11","article-title":"Subconjunctival injections of triamcinolone acetonide to treat uveitic macular edema","volume":"13","author":"Qu","year":"2020","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.015_bib52","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/eye.2008.114","article-title":"Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis","volume":"23","author":"Roesel","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2026.06.015_bib53","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/17425247.2021.1867532","article-title":"Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapies","volume":"18","author":"Hancock","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.survophthal.2026.06.015_bib54","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/IAE.0000000000004132","article-title":"Suprachoroidal Triamcinolone Acetonide for refractory postoperative cystoid macular edema","volume":"44","author":"Momenaei","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.06.015_bib55","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.37765\/ajmc.2023.89324","article-title":"Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with noninfectious uveitis: an in-depth look at efficacy and safety","volume":"29","author":"Yeh","year":"2023","journal-title":"Am J Manag Care"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T19:22:42Z","timestamp":1783797762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726000883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"alternative-id":["S0039625726000883"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.06.015","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of different intraocular therapies for non-infectious uveitis: A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}